Ateneo - UPO

Teaching is given in the form of: i) classroom lectures; ii) practicals including literature and data searches; iii) discussions of case studies. Additionally, the course is enriched by 3 h seminars by the CEO of the start up company ChemiCare (Dr. Beatrice Riva) who will provide additional and personal insights into R&D process and drug development with particular reference to GXP compliance and ICH (international Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use) guidelines.

The students, in an individual effort, will be required to search and retrieve data on a recently developed drug for skin disorders and critically evaluate either preclinical and/or clinical aspects of the R&D process as described in a peer reviewed publication of choice .